Werbung
Werbung

LUCD

LUCD logo

Lucid Diagnostics Inc. Common Stock

1.23
USD
Gesponsert
+0.04
+2.94%
08. Jan., 15:27 UTC -5
Geschlossen
exchange

Nach-Markt

1.23

0.00
0.00%

LUCD Ergebnisberichte

Positives Überraschungsverhältnis

LUCD übertreffen die 7 der letzten 17Schätzungen.

41%

Nächster Bericht

Datum des nächsten Berichts
23. März 2026
Estimate for Q4 25 (Revenue/ EPS)
$1.49M
/
-$0.10
Implizierte Änderung von Q3 25 (Revenue/ EPS)
+22.68%
/
--
Implizierte Änderung von Q4 24 (Revenue/ EPS)
+24.11%
/
-44.44%

Lucid Diagnostics Inc. Common Stock earnings per share and revenue

On 12. Nov. 2025, LUCD reported earnings of -0.10 USD per share (EPS) for Q3 25, beating the estimate of -0.11 USD, resulting in a 11.03% surprise. Revenue reached 1.21 million, compared to an expected 1.38 million, with a -12.52% difference. The market reacted with a +6.73% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 8 analysts forecast an EPS of -0.10 USD, with revenue projected to reach 1.49 million USD, implying an increase of 0.00% EPS, and increase of 22.68% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
AngioDynamics, Inc.
Report Date
06. Jan. 2026 For Q2 26
Estimate
-$0.10
Aktuell
$0.00
Überraschung
+100.00%
FAQ
For Q3 2025, Lucid Diagnostics Inc. Common Stock reported EPS of -$0.10, beating estimates by 11.03%, and revenue of $1.21M, -12.52% below expectations.
The stock price moved up 6.73%, changed from $1.04 before the earnings release to $1.11 the day after.
The next earning report is scheduled for 23. März 2026.
Based on 8 analysts, Lucid Diagnostics Inc. Common Stock is expected to report EPS of -$0.10 and revenue of $1.49M for Q4 2025.
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung